Author: hme0988
-
Predicting Disease Risk and Improving Patient Outcomes
Investigators are advancing research to support proactive responses in diagnosing and preventing chronic diseases. Across departments, scientists at Feinberg are pursuing new ways of testing to determine a person’s risk of developing chronic conditions.
-
Investigating the Youth Mental Health Crisis
Many have posited the reason for rising mental health concerns among kids and teens – social media, the COVID-19 pandemic, stigma, etc. But the reality is there is a constellation of factors that contribute to this crisis, according to experts.
-
Top 3 Episodes of the Breakthroughs Podcast in 2024
The Breakthroughs podcast released 17 episodes in 2024, on topics ranging from biological age research to new insights in inflammation and microbiome science, as well as health equity research and community engagement efforts.
-
Addressing the Growing Need for Implementation Science
Translating medical research findings from the research laboratory into patient care, otherwise known as from “bench to bedside,” is far more complex than it sounds, but is imperative to improve human health.
-
Esteemed Molecular Biologist Named Winner of 2025 Kimberly Prize
Distinguished biochemist Ron Evans, PhD, director of the Gene Expression Laboratory and professor at the Salk Institute for Biological Studies, has been named the winner of the annual $250,000 Kimberly Prize in Biochemistry and Molecular Genetics.
-
Feinberg Scientists Identified As ‘Highly Cited’ on 2024 Clarivate List
Ten Feinberg faculty members were named to the 2024 “Highly Cited Researchers” list, published by Clarivate Analytics.
-
Accelerating Discoveries in Immunobiology Through Collaboration
Just two years out from its launch, the Center for Human Immunobiology has quickly become a bustling hub for collaborative efforts to understand the molecular mechanisms of the immune system and translate discoveries into innovative cures for immune-regulated diseases.
-
Improving the Science and Treatment of Glioblastoma
The average length of survival for glioblastoma has failed to improve since it was first identified in scientific literature nearly 100 years ago. Despite this, scientists at Feinberg remain steadfast in their commitment to improving the understanding and treatment of glioblastoma through rigorous research initiatives and clinical trials.
-
Medical School Tops Research Funding in 2024
Feinberg principal investigators secured $742.2 million dollars in research funding and awards during the 2023-24 fiscal year, a five percent increase over the previous year, and the largest amount in the school’s history.
-
Hauser Named 2024 Tripartite Prize Awardee
Alan Hauser, MD, PhD, professor and vice chair of Microbiology-Immunology, has been named the winner of the 2024 Tripartite Legacy Faculty Prize in Translational Science and Education.
